{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:04:22Z","timestamp":1748977462353},"reference-count":27,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2002,9,13]],"date-time":"2002-09-13T00:00:00Z","timestamp":1031875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2002,9,13]],"date-time":"2002-09-13T00:00:00Z","timestamp":1031875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1034\/j.1600-0404.2002.01323.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T02:29:48Z","timestamp":1047349788000},"page":"236-239","source":"Crossref","is-referenced-by-count":14,"title":["Visual recovery in a man with the rare combination of mtDNA 11778 LHON mutation and a MS-like disease after mitoxantrone therapy"],"prefix":"10.1155","volume":"106","author":[{"given":"C.","family":"Buhmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gbadamosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Heesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2002,9,13]]},"reference":[{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/brain\/118.2.319","article-title":"The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation","volume":"118","author":"RIORDAN-EVA","year":"1995","journal-title":"Brain"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0002-9394(14)76784-4","article-title":"The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation","volume":"111","author":"NEWMAN","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jmg.36.7.505","article-title":"Mitochondrial DNA analysis: polymorphisms and pathogenicity","volume":"36","author":"CHINNERY","year":"1999","journal-title":"J Med Genet"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0925-4439(95)00037-5","article-title":"mtDNA mutations in Leber's hereditary optic neuropathy","volume":"1271","author":"SAVONTAUS","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0404.1998.tb07301.x","article-title":"Is the mitochondrial DNA involved in determining susceptibility to multiple sclerosis?","volume":"98","author":"KALMAN","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB6|cit6","first-page":"10","article-title":"Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation","volume":"12","author":"STONE","year":"1992","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/bjo.84.5.534","article-title":"Variable pattern of visual recovery of Leber's hereditary optic neuropathy","volume":"84","author":"NAKAMURA","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/115.4.979","article-title":"Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation","volume":"115","author":"HARDING","year":"1992","journal-title":"Brain"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ana.410360121","article-title":"Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis","volume":"36","author":"KELLAR-WOOD","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1212\/WNL.43.12.2720","article-title":"Association of the 11778 mitochondrial DNA mutation and demyelinating disease","volume":"43","author":"FLANIGAN","year":"1993","journal-title":"Neurology"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0022-510X(95)00287-C","article-title":"Leber's hereditary optic neuropathy with the 11 778 mtDNA mutation and white matter disease resembling multiple sclerosis: clinical, MRI and MRS findings","volume":"135","author":"JANSEN","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0404.1995.tb07016.x","article-title":"Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation","volume":"91","author":"OLSEN","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0404.1997.tb00257.x","article-title":"LHON mutations in Italian patients affected by multiple sclerosis","volume":"96","author":"LEUZZI","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"POSER","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/brain\/107.3.951","article-title":"Bilateral optic neuritis. A long-term follow-up","volume":"107","author":"PARKIN","year":"1984","journal-title":"Brain"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/101.3.495","article-title":"Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis","volume":"101","author":"COMPSTON","year":"1978","journal-title":"Brain"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.32.2.81","article-title":"Leber's hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations","volume":"32","author":"RIORDAN-EVA","year":"1995","journal-title":"J Med Genet"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB18|cit18","unstructured":"KESSELRING J. 1997"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB19|cit19","first-page":"230","article-title":"Doyne lecture. The significance of optic neuritis","volume":"103","author":"MCDONALD","year":"1983","journal-title":"Trans Ophthalmol Soc U K"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB20|cit20","unstructured":"MATTHEWS B. Symptoms and signs of multiple sclerosis - optic neuritis"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jnnp.62.1.85","article-title":"Neuromyelitis optica (Devic's syndrome): no association with the primary mitochondrial DNA mutations found in Leber hereditary optic neuropathy","volume":"62","author":"COCK","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB22|cit22","first-page":"939","article-title":"Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees","volume":"49","author":"HOWELL","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1017\/S0317167100041263","article-title":"A controlled trial of mitoxantrone in multiple sclerosis:serial MRI evaluation at one year","volume":"21","author":"BASTIANELLO","year":"1994","journal-title":"Can J Neurol Sci"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s004150050066","article-title":"Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome","volume":"244","author":"MILLEFIORINI","year":"1997","journal-title":"J Neurol"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00588624","article-title":"Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone","volume":"37","author":"KRAPF","year":"1995","journal-title":"Neuroradiology"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF02191555","article-title":"Treatment of multiple sclerosis with mitoxantrone","volume":"242","author":"MAUCH","year":"1992","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1034\/j.1600-0404.2002.01323.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000008163","article-title":"Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis","volume":"43","author":"CURSIEFEN","year":"2000","journal-title":"Eur Neurol"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0404.2002.01323.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0404.2002.01323.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1034\/j.1600-0404.2002.01323.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:44:31Z","timestamp":1671540271000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1034\/j.1600-0404.2002.01323.x"}},"subtitle":["Visual recovery in a man with LHON and MS"],"short-title":[],"issued":{"date-parts":[[2002,9,13]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"URL":"https:\/\/doi.org\/10.1034\/j.1600-0404.2002.01323.x","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9,13]]}}}